| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0084 | 0.9 |